Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan

[1] Barnett K(2012)Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study Lancet 380 37-43

[2] Mercer SW(2014)Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies PLoS ONE 9 3806-S207

[3] Norbury M(2018)Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population Sci Rep 8 S195-1001

[4] Watt G(2018)Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: a systematic review PLoS ONE 13 310-146

[5] Wyke S(2022)13. Older adults: standards of medical care in diabetes-2022 Diabetes Care 45 983-1418

[6] Guthrie B(2018)Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases Int J Environ Res Public Health 15 141-799

[7] Violan C(2016)Screening tool for older persons’ appropriate prescriptions for Japanese: report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the elderly” Geriatr Gerontol Int 16 1410-2498

[8] Foguet-Boreu Q(2010)The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study J Gen Intern Med 25 792-96

[9] Flores-Mateo G(2010)Severe hypoglycemia and risks of vascular events and death N Engl J Med 363 53-223

[10] Aoki T(2010)The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study BMJ 340 2461-268

[1] Barnett K(2012)Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study Lancet 380 37-43

[2] Mercer SW(2014)Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies PLoS ONE 9 3806-S207

[3] Norbury M(2018)Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population Sci Rep 8 S195-1001

[4] Watt G(2018)Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: a systematic review PLoS ONE 13 310-146

[5] Wyke S(2022)13. Older adults: standards of medical care in diabetes-2022 Diabetes Care 45 983-1418

[6] Guthrie B(2018)Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases Int J Environ Res Public Health 15 141-799

[7] Violan C(2016)Screening tool for older persons’ appropriate prescriptions for Japanese: report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the elderly” Geriatr Gerontol Int 16 1410-2498

[8] Foguet-Boreu Q(2010)The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study J Gen Intern Med 25 792-96

[9] Flores-Mateo G(2010)Severe hypoglycemia and risks of vascular events and death N Engl J Med 363 53-223

[10] Aoki T(2010)The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study BMJ 340 2461-268